Gelonghui, Feb. 29丨Kehua Biotech (002022.SZ) said on the investor interactive platform that the company's subsidiary Focus Diagnostics focuses on R&D, production and sales of microfluidic POCT instruments and reagents.
科华生物(002022.SZ)：子公司焦点诊断专注于微流控POCT仪器与试剂的研发、生产和销售
Kehua Biology (002022.SZ): The subsidiary focuses on R&D, production and sales of microfluidic POCT instruments and reagents
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.